找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Cytochrome P450; In Vitro Methods and Zhengyin Yan,Gary W. Caldwell Book 2021 The Editor(s) (if applicable) and The Author(s), under exclus

[復(fù)制鏈接]
樓主: Amalgam
11#
發(fā)表于 2025-3-23 09:55:41 | 只看該作者
12#
發(fā)表于 2025-3-23 17:52:34 | 只看該作者
13#
發(fā)表于 2025-3-23 18:28:29 | 只看該作者
14#
發(fā)表于 2025-3-24 01:37:59 | 只看該作者
15#
發(fā)表于 2025-3-24 04:11:19 | 只看該作者
Assessment of Cytochrome P450 Metabolic Clearance Using Hepatocyte Suspension,tochrome P450 (CYP)-mediated metabolism. Therefore, hepatic clearance is undeniably one of the most critical pharmacokinetic parameters. In the early stages of drug discovery, the in vitro hepatic metabolic stability assay carries great importance as it provides a time- and cost-effective route for
16#
發(fā)表于 2025-3-24 06:33:39 | 只看該作者
Cytochrome P450 Knock-Out Assay with Nonselective Inhibitors,an also play a similar role in the metabolism of drugs and other xenobiotics. Oftentimes, CYPs and non-CYP enzymes can share substrate specificity and collectively catalyze oxidative metabolic reactions of the same drug. Therefore, it is of importance in drug discovery to differentiate CYP-mediated
17#
發(fā)表于 2025-3-24 12:50:26 | 只看該作者
Differentiation of Cytochrome P450-Mediated from Non-CYP-Mediated Metabolism: Aldehyde Oxidase and as medicinal chemistry strategies evolve to reduce cytochrome P450 (CYP) related drug metabolism. Consequently, there is a need for a differentiation strategy for test compounds to be characterized from those of CYP and molybdenum-containing hydroxylases. Herein, general procedures to identify acti
18#
發(fā)表于 2025-3-24 16:20:54 | 只看該作者
In Vitro Reaction Phenotyping of Cytochrome P450 Enzymes,ity in order to assess clinical drug–drug interaction potential and estimate its relative contribution to the overall metabolic clearance in human. CYP phenotyping is commonly carried out using recombinant CYPs, and/or human liver microsomes (HLM) in combination with isoform-specific chemical inhibi
19#
發(fā)表于 2025-3-24 20:26:48 | 只看該作者
20#
發(fā)表于 2025-3-25 02:12:46 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-25 13:51
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
临邑县| 蕲春县| 合肥市| 通海县| 靖西县| 即墨市| 尚义县| 北辰区| 盘山县| 斗六市| 唐山市| 循化| 波密县| 青田县| 巫山县| 观塘区| 乌拉特前旗| 梁平县| 永平县| 永善县| 凤山县| 沙河市| 鹤岗市| 海阳市| 临澧县| 望谟县| 巴里| 天柱县| 海晏县| 衡水市| 芦溪县| 博兴县| 隆安县| 岳普湖县| 崇义县| 漳州市| 石城县| 河津市| 偏关县| 抚宁县| 叙永县|